— Know what they know.
Not Investment Advice
Also trades as: CGN.DE (XETRA) · $vol 0M

CI NYSE

Cigna Corporation
1W: -2.7% 1M: +9.7% 3M: +0.6% YTD: +6.9% 1Y: -0.6% 3Y: +1.3% 5Y: +55.8%
$298.28
-7.50 (-2.45%)
Pre-Market: $297.06 (-1.21, -0.41%)
Weekly Expected Move ±3.7%
$284 $296 $307 $318 $330
NYSE · Healthcare · Medical - Healthcare Plans · Tech Score Strong Buy · Power 77 · $78.8B mcap · 263M float · 0.631% daily turnover · Short 51% of daily vol
Credit Risk of going bust: lower than 60% of companies Debt: 28.8% of company value Bonds: $793.3M held by 441 funds, 82 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $8.55 (down 97%), Cigna Corporation would be worth roughly what it owes.
Total debt $31.88B against a stock market value of $78.82B.
Distance to default 6.16 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $17.34B (short-term plus half of long-term), stock volatility 33.6%; Altman Z'' 1.50. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Supply Chain Overview

3 relationships
2
As Filer
counterparties named
1
As Counterparty
mentioned by others
1
Rel. Types
2022-01-03
Earliest Filing
2025-09-04
Latest Filing
partner: 2

Counterparties (Filed by CI)

2 relationships

Companies named in CI's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Citigroup Global Markets Inc. — partner Underwriter representative in the offering of Senior Notes. 2025-09-04 View
Morgan Stanley & Co. LLC MS-PL partner Underwriter representative in the offering of Senior Notes. 2025-09-04 View

Mentioned As Counterparty

1 mentions

Other companies that named CI in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
NEUE Bright Health Group Inc. investor Purchaser of Series A Convertible Perpetual Preferred Stock 2022-01-03 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-09 Officer/Director Change View
2026-09-30 Regulation FD; Exhibits View
2026-07-30 Earnings Release; Exhibits View
2026-05-13 Regulation FD View
2026-04-30 Earnings Release; Exhibits View
2026-04-27 Shareholder Vote View
2026-03-03 Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem View
2026-02-27 Regulation FD Disclosure View
2026-02-05 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-18 Other Events View
2025-10-30 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-20 Departure/Election of Directors; Appointment of Officers View
2025-09-04 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Other Events; Fin Agreement View
2025-09-02 Regulation FD Disclosure View
2025-07-31 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-28 Departure/Election of Directors; Appointment of Officers View
2025-06-02 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-05-20 Regulation FD Disclosure View
2025-05-02 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-04-28 Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms